Share:

Share on Facebook  Share on Twitter Share via Mail

Society for Maternal-Fetal Medicine 43rd Annual Pregnancy Meeting

Join our Center for Maternal-Fetal Precision Medicine team at the 43rd Annual Society for Maternal-Fetal Medicine (SMFM) Conference in San Francisco! We are excited to see those planning to attend. Connect with us at the following activities and presentations and stop by the Fetal Treatment Center’s Booth #417

Monday, February 6

Post Graduate Course: Evolution of Fetal Anomalies from First to Third Trimester Scan
Screening and Diagnostic Genetic Testing
3:30 – 4:20 PM | Room 2005, Moscone West, Level 2
Presenter: Mary E. Norton, MD

Tuesday, February 7

President’s Workshop: Developing an Optimal Maternal-Fetal Medicine Ultrasound Practice
Integration of Genetics into Ultrasound Practice
1 – 1:20 PM | Room 2009, Moscone West, Level 2
Presenter: Mary E. Norton, MD

Breakout Group 4: Day 1 Discussion
Current and emerging approaches to managing the pregnant person with obstetric ultrasound
2 – 5:30 PM | Room 2009, Moscone West, Level 2
Co-Presenter: Mary E. Norton, MD

Post Graduate Course: Fetal Therapy: Controversies and Updates
Is Fetal Gene Therapy on the Horizon?
3:55 – 5 PM | Room 2006, Moscone West, Level 2
Presenter: Tippi C. MacKenzie, MD

Wednesday, February 8

President’s Workshop
Developing an Optimal Maternal-Fetal Medicine Ultrasound Practice
1 – 1:20 PM | Room 2009, Moscone West, Level 2
Co-Presenter: Mary Norton, MD

Diversity, Equity and Inclusion Reception
5:30 7 PM | Room 2014, Moscone West, Level 2
The reception celebrates the graduation of the first-ever Emerging Leaders Program Class of 2022-2023 and honors the 2023 SMFM Mentorship in Diversity, Equity, and Inclusion Awardee.

Opening Reception with Exhibitors
6 – 8 PM | Exhibit Hall, Moscone West, Level 1
Sponsored by UCSF Benioff Children’s Hospitals Fetal Treatment Center

University of California Annual Reception at SMFM
Hosted by UCSF Fetal Treatment Center and Maternal Fetal-Medicine Division
8 – 11 PM | Marriott Marquis, 780 Mission Street, Foothill F, Second Floor
RSVP Alison.Wenz@ucsf.edu

Thursday, February 9 

Poster Session I
10:30 AM – 12 PM | Exhibit Hall, Moscone West, Level 1

Optimal timing of delivery for growth-restricted fetuses with gastroschisis: A decision analysis (Abstract #152). Claire Packer, Rachel Pilliod, Aaron Caughey, Teresa Sparks.

Resolution of hydrops fetalis: When does it occur? (Abstract #353). Teresa Sparks, Billie Lianoglou, Nuriye Sahin Hodoglugil, Kate Swanson, Sarah Downum, Patrick Devine, Ugur Hodoglugil, Jessica Van Ziffle, Mary Norton.

Poster Session II
4 – 5 PM | Exhibit Hall, Moscone West, Level 1

Rare Single Gene Etiologies at Risk for Fetal Anemia (Abstract #410). Billie Lianoglou, Sarah Downum, Juan Gonzalez, Angie Jelin, Mara Rosner, Mary Norton, Teresa Sparks.

Molecular Diagnoses in Fetuses with Megacystis/LUTO by Prenatal Ultrasound (Abstract #411). Bobby Brar, Karin Blakemore, Jena Miller, Kristen Miller, Chrissy Hertenstein, Billie Lianoglou, Teresa Sparks, Mary Norton, Angie Jelin.

Friday, February 10

Poster Session III—Oral Concurrent Sessions
2:45 – 3 PM | Room 3022, Moscone West, Level 3

Patient perspectives on the utility and impact of prenatal genetic exome sequencing (Abstract #56). Kate Swanson, Nuriye Sahin-Hodoglugil, Teresa Sparks, Sara Ackerman, Billie Lianoglou, Sarah Downum, Mary Norton.

Poster Session IV—Oral Concurrent Sessions
3:15 – 3:30 PM | Room 3022, Moscone West, Level 3

Postnatal phenotyping after negative prenatal exome sequencing for fetal anomalies (Abstract #58). Teresa Sparks, Billie Lianoglou, Kate Swanson, Ugur Hodoglugil, Mary Norton. 

3:45 – 5:15 PM | Exhibit Hall, Moscone West, Level 1

Genetic etiologies of fetal brain malformations: How does gene panel coverage compare to exome sequencing? (Abstract #1045). Kate Swanson, Matt Shear, Billie Lianoglou, Mary Norton, Teresa Sparks.

Prenatal exome sequencing versus targeted gene panels for evaluation of fetal congenital heart defects.(Abstract #1087). Matt Shear, Kate Swanson, Mary Norton, Teresa Sparks.

Deep phenotyping expands our knowledge of fetal manifestations of genetic disease. (Abstract #1170). Teresa Sparks, Billie Lianoglou, Nuriye Sahin Hodoglugil, Kate Swanson, Sarah Downum, Anne Slavotinek, Patrick Devine, Ugur Hodoglugil, Jessica Van Ziffle, Mary Norton.